



from the South Indian BCG trial area

by HPLC by Daisy Vanitha, J et al.
RESEARCH COMMUNICATIONS 
 
CURRENT SCIENCE, VOL. 82, NO. 2, 25 JANUARY 2002 189
†For correspondence. (e-mail: trcicmr@md3.vsnl.net.in(bact3)) 
Identification of a group of 
nontuberculous mycobacteria isolated 
from the South Indian BCG trial area 
by HPLC 
 
J. Daisy Vanitha*, Chandra Immanuel*, 
Bogumila Szponar‡, Lennart Larsson‡ and 
C. N. Paramasivan*,† 
*Tuberculosis Research Centre (Indian Council of Medical  
Research), Chennai 600031, India 
‡Department of Medical Microbiology, Dermatology and Infection, 
University of Lund, Sweden 
 
Twenty-five isolates of nontuberculous mycobacteria 
isolated from the South Indian BCG trial area were 
analysed by high performance liquid chromatogr-
phy (HPLC) for mycolic acid pattern. The chroma-
tograms differentiated the isolates into four species, 
namely M. terrae complex, M. intracellulare, M. para-
fortuitum and M. fortuitum. Three strains were un- 
identified, one of which did not show any mycolic 
acid peaks. All isolates had been identified as M. 
diernhoferi by biochemical methods in a previous 
study. Nineteen of the isolates were analysed by gas 
chromatography-mass spectrometry (GC-MS) for 
the presence of tuberculostearic acid, 2-eicosanol 
and mycolic acid cleavage products, and were classi-
fied as nonchromogens or rapidly growing mycobac-
teria. The results show that HPLC can discrimnate 
the described mycobacterial species better than bio-
chemical methods and GC-MS. 
 
IDENTIFICATION of nontuberculous mycobacteri  
(NTM) is important for epidemiological studies and a 
better understanding of the pathogenesis of the diseases 
they cause1,2. The fact that NTM may cause opportunis-
tic infections among HIV patients necessitates rapid 
species identification for appropriate management of 
this increasingly important group of patients3,4. Identif- 
cation of mycobacteria has traditionally been based on 
growth characteristics and a battery of time-c nsu ing 
biochemical tests. Unfortuna ely, the specificity and 
sensitivity of these tests in recognizing new species are 
low5. Only two techniques seem to have the potential to 
recognize new species of mycobacteria, namely, genetic 
and chromatographic analysis6. Reverse-phase high per-
formance liquid chromatography (HPLC) of the high 
molecular weight mycolic acids is rapid and, unlike 
genetic probes, not limited to the identification of only 
a few species7,8. The present retrospective study was 
performed in order to evaluate whether mycolic acid 
analysis by HPLC could be used as a substitute for bio-
chemical tests, and also to characterize NTM by gas 
chromatography-mass spectrometry (GC-MS) lipid pro-
file. A library of HPLC chromatograms was constructed 
using reference strains of mycobacteria since differ-
ences in instrumentation and analytical condtions could 
significantly affect the chromatographic profiles. The 
chromatograms were visually matched with the pattern 
recognition manual of Centers for Disease Control and 
Prevention (CDC)9.  
 Twenty-five isolates of NTM obtained from the envi-
ronment and sputum samples from the South Indian 
BCG trial area were tested by HPLC. These isolat s 
were identified by growth characteristics and biochemi-
cal tests done in a previous study as M. diernhoferi10. 
Seven of the isolates were sent to CDC for pattern con-
firmation and 19 of them to Lund University for GC-
MS lipid profile. Staphylococcus aureus ATCC 29213 
was used as a negative control. 
 Mycolic acid analysis was performed according to the 
method of Butler t al.9. In brief, 2 to 3 loopfuls of ap-
proximately 3-week-old culture on L–J medium were 
saponified with methanolic potassium hydroxide at 
121°C for one hour. The mycolic acids were extracted 
into chloroform in an acidic environment. After neu-
tralization, mycolic acids were derivatized with 2,4¢-
dibromoacetophenone and dicyclohexyl-18-crown-6-
ether in acetonitrile and converted to UV absorbing p-
bromo phenacyl esters. The samples were clarified with 
acidic methanol and evaporated. The dried samples 
were reconstituted in methylene chloride and analysed 
using a reverse-phase C18 column (4.6 mm ´  250 mm) 
packed with 5 µm silica particles (Spinco Biotech,  
India) with the UV detector set at 254 nm. A solvent 
gradient system described by Hagen was followed11. 
Briefly, after injection, the initial solvent mixture 
(methanol : methylene chloride 70 : 30) was maintained 
for one minute at a constant flow rate of 1.5 ml/min. 
Over the next 20 min, the solvent composition was 
changed to 45 : 5 . During the next 0.5 min the solvent 
composition was changed back to the initial composition 
and the solvent mixture was held to equilibrate the col-
umn for five minutes. The total elution time was 
26.5 min. Peaks eluted between 6 and 25 min were used 
for visual comparison. For GC-MS analysis, mycobacte-
ria were heated in 1 M methanolic hydrogen chloride and 
extracted using n-heptane. The extracts were introduced 
and separated on a fused silica capillary column by us-
ing a nonpolar stationary phase. Peak identification was 
performed by using MS in the electron impact mode12. 
 All the reference strains analysed gave HPLC chro-
matograms, which when compared visually, resembled 
the patterns reported by the CDC. The information on 
growth rate already available makes visual comparison 
easy and accurate. The results of 25 test isolates are 
summarized in Table 1. By visual comparison with 
CDC manual, 12 were identified as M. terrae complex, 
7 as M. intracellulare, two as M. parafortuitum and one 
as M. fortuitum. Two strains could not be identified be-
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Table 1. Summary of results obtained by HPLC and GC-MS 
 GC-MS 
 MACP 
Isolate Source HPLC-TRC HPLC-CDC TBSA 2-eicosanol C 22:0 C 24:0 C 26:0 
 
B92/1 Water M. terrae complex  + + + + + 
B151/2 Water M. terrae complex  + + + + + 
TS09865 Sputum M. terrae complex  + – + + – 
TS10088 Sputum M. terrae complex M. terrae complex + + + + + 
TS10408 Sputum M. terrae complex M. terrae complex – + + + – 
TS11431 Sputum M. terrae complex M. terrae complex + + + + + 
TS11531 Sputum M. terrae complex  + + + + + 
TS11589 Sputum M. terrae complex  + + + + + 
TS11601 Sputum M. terrae complex  + + – – – 
TS16563 Sputum M. terrae complex M. terrae complex + + + + – 
TS19592 Sputum M. terrae complex M. terrae complex + + + + – 
TS16040 Sputum M. terrae complex  … … … … … 
B132/124 Water M. intracellulare  + + + + – 
TS10983 Sputum M. intracellulare  + + + + – 
TS11343 Sputum M. intracellulare  + + + + + 
TS11392 Sputum M. intracellulare  + + + + – 
TS10962 Sputum M. intracellulare  … … … … … 
TS16202 Sputum M. intracellulare  … … … … … 
TS17657 Sputum M. intracellulare  … … … … … 
A145/3 Soil Mycobacterium sp. NCP + + + + – 
TS10064 Sputum Mycobacterium sp. NCP + + + + + 
TS11378 Sputum M. fortuitum  + – + + + 
TS10186 Sputum M. parafortuitum  … … … … … 
TS17197 Sputum M. parafortuitum  … … … … … 
TS15727 Sputum No peaks  – – – – – 
TRC, Tuberculosis Research Centre; CDC, Centers for Disease Control and Prevention; TBSA, Tuberculostearic acid; C22:0, 
Docosanoic acid; C24:0, Tetracosanoic acid; C26:0, Hexacosanoic acid; NCP, No common pattern, …, Not done. 
 
 
  M. terrae M. intracellulare 
  
 
  NCP M. fortuitum 
  
 
Figure 1. Representative chromatograms. 
 
 
cause of unusual patterns. One strain had no peaks. 
Representative chromatograms are shown in Figure 1. 
Five of the twelve M. terrae isolates and the two uni-
dentified species were sent to CDC for mycolic acid 
analysis to confirm the results. CDC reported similar 
patterns and the unidentified species were referred as no 
common pattern (NCP). Of the 25 isolates, 11 of M. 
terrae, 4 of M. intracellulare and both the isolates of 
NCP and M. fortuitum, and the one with no peaks were 
analysed by GC-MS. The lipid markers analysed were 
tuberculostearic acid (TBSA, 10-methyl octadecanoic 
acid), 2-eicosanol (2-OH C20 : 0) and the three mycolic 
acid cleavage products (MACP)–docosanoic acid 
(C22 : 0), tetracosanoic acid (C24 : 0) and hexacosanoic 
acid (C26 : 0). The presence of 2-eicosanol in all but 
three isolates demonstrated that the mycobacteria be-
long to species containing wax ester mycolates. The 
isolate of M. fortuitum and unexpectedly, one of the M. 
terrae strains did not contain any 2-eicosanol. The ab-
sence of TBSA in one of the isolates could not be ex-
plained; this isolate was identified as M. terrae by CDC. 
The isolate that did not have any mycolic acid showed 
absence of all the lipid markers studied.  
 It is reported that many species of mycobacteria can-
not be identified by biochemical methods and precise 
identifcation is uncertain13. This type of discrepancy 
has been found between biochemical methods and Ac-
cuprobe or 16S rRNA gene sequencing14. Our observa-
tion confirmed this phenomenon since the test isolates 
we e previously identified as M. diernhoferi by bio-
chemical methods, whereas by using HPLC they were 
classified as belonging to four different species (M. ter-
rae complex, M. intracellulare, M. fortuitum and M. 
parafortuitum). Among these, M. intracellulare, M. for-
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tuitum and M. parafortuitum have three clusters of my-
colic acid peaks. The majority of the test isolates were 
identified as M. terrae, which has only two clusters, 
similar to M. diernhoferi. The good agreement between 
our HPLC results and those from CDC shows that, in 
spite of the subjectivity in identification by visual  
recognition and differences in instrumentation and ana-
lytical conditions, the chromatographic patterns were 
consistent, clearly demonstrating inter-laboratory 
agreement. While the GC-MS data classified the test 
isolates into rapid growers or nonchromogens, HPLC 
profiles further differentiated the nonchromogens into 
three groups, namely M. terrae, M. intracellulare nd 
NCP. 
 This is a report on the comparison of biochemical 
methods and HPLC for identification of mycobacteria 
conducted in India. It was found that mycolic acid 
analysis has high discriminating power and is rapid 
since it generates results within a day, in contrast to 
biochemical methods. The cost of HPLC is reported to 
be 60% less than that of the conventional biochemical 
tests and 89% less than that of isotopic probes13. How-
ever, for those species that cannot be identified by 
HPLC, use of a combination of identification methods 
is recommended15.  
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Blood flow through the cardiovascular system is as-
sociated with erythrocyte aggregation and deform-
ability. This study is aimed at determining the 
changes in these parameters associated with human
ageing. Blood samples of healthy subjects of differ-
ent age groups (ranging from 20 to 65 years) were 
obtained by venepuncture in test tubes containing 
citrate phosphate dextrose as an anticoagulant. The 
aggregation of erythrocytes, a reversible process, 
was determined by the changes in laser-transmitted 
intensity during gravitat onal sedimentation of 
erythrocytes and their formed aggregates. The de-
for ability of erythrocytes was measured by the fil-
tration of erythrocyte suspension through cellulose 
membrane. The erythrocyte aggregation increases 
significantly (P £ 0.008) in age groups III (41–50 
years) and IV (51–65 years) compared to that of con-
trols (20–30 years). In contrast to this, the erythro-
cyte deformability in these groups compared to that 
of the control group, is significantly (P £ 0.04) re-
duced. These haemorheological ch nges may lead to 
disturbed blood flow, and thus could contribute to 
the increased incdence of circulatory disorders in 
the elderly. 
 
HUMAN blood contains cells suspended in the plasma. 
The cellular constituents include erythrocytes, leuco-
cytes and thrombocytes. Erythrocytes form the majority 
of the cellular constituents (up to 98%); hence any 
change in their flow behaviour affects the blood flow 
through the cardiovascular system. Erythrocyte 
aggregation is one of the most important factors which 
determines the blood flow at low flow-rates in the 
microcirculation. The growth process of the chain-like 
three-dimensional structure of the aggregates depends 
on the deformation of the shape of the outermost cell 
(concave or convex) available for attachment to indi-
vidual erythrocytes or small-size aggregates1. Formation 
of these aggregates represents the balance of energies at 
the cell surface, contributed by the plasma proteins, 
erythrocyte mebrane charge and its deformability2. 
Under stasis conditions large aggregates are formed, 
and with increasing flow rate these are broken into 
sm lle aggregates and fi ally to individual flattened 
discs of cells aligned in the flow direction2. The major 
